(Q73269099)
Statements
Front-line treatment of advanced breast cancer with docetaxel and epirubicin: a multicenter phase II study (English)
D Mavroudis
A Alexopoulos
N Ziras
N Malamos
C Kouroussis
S Kakolyris
S Agelaki
K Kalbakis
N Tsavaris
A Potamianou
G Rigatos